Cialis versus viagra
Cialis levitra viagra vs vs. other hand, clearly works for 36 hours or more, making it an ideal choice for men who are very sexually active, Murdock says. He still gives Viagra the edge in treating female sexual dysfunction, a yet-unapproved but potentially lucrative use. Pfizer is five years ahead of the competition in that area. Murdock also notes another advantage for Levitra. Viagra patients have been ordering high-dose pills and splitting them, because all doses come at the same cost. Levitra, a small, hard orange pill, is much more difficult to cut, so at least it won't have to deal with sales reduced by pill splitting. More Monday Matchups & 160;& 160;Who wins this Monday matchup? & 160; Viagra & 160; Levitra & 160; It's a tie & 160; Neither one is a winner & 160; & 160; >& 160;& 160;" onClick='newWindow = window.open("","pollwindow","resizable=yes,scrollbars=yes,height=472,width=524"); newWindow.focus();'> 1 of 1 E-mail Print Comments Request Reprints E-Mail Newsletters My Yahoo! RSS '); --> News Headline
Cialis vs viagra
S More From Forbes.com Special Reports SitemapHelpContact UsInvestment NewslettersForbes ConferencesForbes MagazinesForbes Autos Ad Information Forbes.com Wireless RSS Reprints Permissions Subscriber Services © 2006 Forbes.com Inc.& 153; All Rights Reserved Privacy Statement Terms, Conditions and Notices Delivered By Tested By Market Data By Market Data By Market Data By American History Luxury Cars Stock quotes are delayed at least 15 minutes for Nasdaq, at least 20 minutes for NYSE AMEX. U.S. indexes are delayed at least 15 minutes with the exception of Nasdaq, Dow Jones Industrial Average and S&P 500 which are 2 minutes delayed. Powered By Financial News - Business News Financial News - Business News Investment Newsletter - Financial Newsletters - Stock Newsletter Polls & Discussions Financial Tools - Stock Trading Tool - Investing Tool - Planning Tools Special Reports Video News - Financial Video Reports Business News - Business Information Retail News - Commerce News - Re 